FDA DEVICE FACTS
Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System
Dexcom, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Dexcom G6 Glucose Program Continuous Glucose Monitoring System (Dexcom Glucose Program System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons age 2 years and older. The Dexcom Glucose Program System is intended to replace fingerstick blood glucose testing for diabetes treatment decisions for persons with diabetes who are not at significant risk of severe hypoglycemia. Interpretation of the Dexcom Glucose Program System results should be based on the glucose trends and several sequential sensor readings over time. The Dexcom Glucose Program System also aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating long-term therapy adjustments. The Dexcom Glucose Program System is also intended to autonomously communicate with digitally connected devices. The Dexcom Glucose Program System can be used alone or in conjunction with these digitally connected devices or services for the purpose of managing diabetes. Same Clinical application Management of diabetes mellitus Same Clinical setting/sites of use Home use Same Principle of Operation Amperometric measurement of current proportional to glucose concentration in interstitial fluid via glucose oxidase chemical reaction. Same Data Presented Estimated Glucose Value (EGV): The EGV is the nominal glucose value presented to the user. Glucose Trend: Based off the glucose rate of change, users are shown their glucose trend with a corresponding arrow. Historical Glucose Data: Users can view their previous six, or twelve hours of glucose data on a graph with high/low glucose thresholds. Time in Range: Users can view the percent of time they spend in their target glucose range based on their configured high/low glucose thresholds. Same Features Connect to Dexcom Share: Users can share their glucose data with up to three followers. Chat with Wellness Coach: Users can chat with a third-party wellness coach for encouragement, education, and motivation regarding their diabetes management. Same Human Factors Easy to understand user interface and user experience. Commonly understood navigation tools and features. Color-coded graphics. Same Transmitter G6 Epoxy Transmitter and G6 Welded Transmitter Same Compatibility with intended environments Compatible with Android OS version 7.0 and above Same for Android Compatible with iOS version 13.2 and above
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。